Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • M&A / Deals
  • LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs
  • M&A / Deals

LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

Pharmaceutical Business Review

Executives from both organisations, including LG AI Research head Woohyung Lim and D D Pharmatech CEO Seulki Lee, attended the event to formalise the partnership.

Read full story

pharminent June 18, 2026 (Last updated: June 19, 2026)

Pharmaceutical Business Review

Executives from both organisations, including LG AI Research head Woohyung Lim and D D Pharmatech CEO Seulki Lee, attended the event to formalise the partnership.

Read full story

Post navigation

Previous: Biogen pens $1bn deal to buy immunology biotech RayThera
Next: GSK claims FDA okay for first oral carbapenem antibiotic

Related Stories

  • M&A / Deals

Solstice Oncology secures $225m to drive porustobart’s development for cancer

pharminent September 10, 2026
  • M&A / Deals

UK’s Claret Capital raises 575m for European biotechs

pharminent September 7, 2026
  • M&A / Deals

GSK wagers up to $1.3B on a different kind of cancer drug

pharminent September 3, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.